Life Technologies, Nanosys in Quantum Dot Licensing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies and Nanosys have entered into a cross-licensing deal to share rights to intellectual property covering fluorescent nanocrystals, which are also called quantum dots.

The firms said that the deal is expected to result in the development of new tools to detect counterfeit products worldwide. The firms said that between them they have over 270 patents and applications, including 84 issued US patents, for using fluorescent nanocrystals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.